Home › NDC Lookup › RxCUI directory › RxCUI 995868

Codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution — RxCUI 995868

RxNorm drug concept · Semantic clinical drug
RxCUI 995868 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 18 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI995868
Official nameCodeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascodeine phosphate 10 MG / guaifenesin 100 MG per 5 ML Oral Solution; codeine phosphate 10 MG / guaiFENesin 100 MG in 5 mL Oral Solution
FDA products mapped12
Package NDCs mapped18
Reported Medicaid activity (SDUD)94,539 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Codeine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Codeine Sulfate tablets are used to treat mild to moderate pain — think post-injury pain or pain after a procedure — when over-the-counter options like ibuprofen or acetaminophen h...
  • You take codeine Sulfate tablets by mouth, typically every 4 hours as needed for pain. The good news is you can take it with or without food — studies show a meal doesn't meaningfu...
  • How do I take it, and does it matter if I take it with food?
  • The most common things people notice are drowsiness, dizziness, nausea, constipation, and sweating — these are typical opioid effects. The ones to take seriously and call 911 about...
📖 Read our full Codeine guide →

🕸️ Concept Web — How Codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution RxCUI 995868

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Codeine 2670
    • Guaifenesin 5032
    • Codeine / guaifenesin 214442
    • Codeine phosphate 2672
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cheratussin 995869
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Codeine / guaifenesin Oral Solution 371616
    • Codeine phosphate / guaifenesin Oral Solution 2649095
    • Codeine / guaifenesin Oral Liquid Product 1154815
    • Codeine / guaifenesin Oral Product 1154816
    • Codeine phosphate / guaifenesin Oral Liquid Product 2661357
    • Codeine phosphate / guaifenesin Oral Product 2663315
    • Codeine / guaifenesin Oral Solution [Cheratussin] 995871
    • Codeine phosphate / guaifenesin Oral Solution [Cheratussin] 2655379
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Codeine phosphate 2 MG/ML 832866
    • Guaifenesin 20 MG/ML 316011
    • Codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution [Cheratussin] 995872
    • Codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML [Cheratussin] 995870

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Codeine phosphate 2 MG/ML SCDC · 832866
  • Guaifenesin 20 MG/ML SCDC · 316011
  • Codeine / guaifenesin Oral Solution SCDF · 371616
  • Codeine phosphate / guaifenesin Oral Solution SCDFP · 2649095
  • Codeine / guaifenesin Oral Liquid Product SCDG · 1154815
  • Codeine / guaifenesin Oral Product SCDG · 1154816
  • Codeine phosphate / guaifenesin Oral Liquid Product SCDGP · 2661357
  • Codeine phosphate / guaifenesin Oral Product SCDGP · 2663315

Brand-Name Concepts

  • Codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution [Cheratussin] SBD · 995872
  • Codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML [Cheratussin] SBDC · 995870
  • Codeine / guaifenesin Oral Solution [Cheratussin] SBDF · 995871
  • Codeine phosphate / guaifenesin Oral Solution [Cheratussin] SBDFP · 2655379
  • Cheratussin Oral Liquid Product SBDG · 1168092
  • Cheratussin Oral Product SBDG · 1168093
  • Cheratussin BN · 995869

📦 FDA Products & Package NDCs

12 products · 18 package NDCs
18 package NDCs map to RxCUI 995868 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-0775-04 118 mL in 1 BOTTLE (0121-0775-04) Guaifenesin and Codeine Phosphate PAI Holdings, LLC 2006-10-01
00121-0775-16 473 mL in 1 BOTTLE (0121-0775-16) Guaifenesin and Codeine Phosphate PAI Holdings, LLC 2006-10-01
00121-1550-00 10 TRAY in 1 CASE (0121-1550-00) / 10 CUP, UNIT-DOSE in 1 T... Guaifenesin and Codeine Phosphate PAI Holdings, LLC 2006-10-01
00121-1550-40 4 TRAY in 1 CASE (0121-1550-40) / 10 CUP, UNIT-DOSE in 1 TR... Guaifenesin and Codeine Phosphate PAI Holdings, LLC 2024-01-10
00121-1775-00 10 TRAY in 1 CASE (0121-1775-00) / 10 CUP, UNIT-DOSE in 1 T... Guaifenesin and Codeine Phosphate PAI Holdings, LLC 2006-10-01
00121-1775-10 10 TRAY in 1 CASE (0121-1775-10) / 10 CUP, UNIT-DOSE in 1 T... Guaifenesin and Codeine Phosphate PAI Holdings, LLC 2006-10-01
00121-1775-40 4 TRAY in 1 CASE (0121-1775-40) / 10 CUP, UNIT-DOSE in 1 TR... Guaifenesin and Codeine Phosphate PAI Holdings, LLC 2024-01-10
50090-1428-00 118 mL in 1 BOTTLE (50090-1428-0) Guaifenesin and Codeine Phosphate A-S Medication Solutions 2014-11-28
50090-6435-00 118 mL in 1 BOTTLE (50090-6435-0) Codeine-Guaifenesin A-S Medication Solutions 2023-04-13
55154-5791-05 5 CUP, UNIT-DOSE in 1 BAG (55154-5791-5) / 5 mL in 1 CUP, U... Guaifenesin and Codeine Phosphate Cardinal Health 107, LLC 2023-06-27
58657-0500-04 120 mL in 1 BOTTLE (58657-500-04) Codeine-Guaifenesin Method Pharmaceuticals, LLC 2014-04-01
58657-0500-16 473 mL in 1 BOTTLE (58657-500-16) Codeine-Guaifenesin Method Pharmaceuticals, LLC 2014-04-01
68071-5173-04 120 mL in 1 BOTTLE (68071-5173-4) Codeine-Guaifenesin NuCare Pharmaceuticals,Inc. 2020-02-12
68788-8361-01 118 mL in 1 BOTTLE (68788-8361-1) Guaifenesin and Codeine Phosphate Preferred Pharmaceuticals Inc. 2023-02-01
69367-0272-04 118 mL in 1 BOTTLE (69367-272-04) Codeine-Guaifenesin Westminster Pharmaceuticals, LLC 2020-07-15
69367-0272-16 473 mL in 1 BOTTLE (69367-272-16) Codeine-Guaifenesin Westminster Pharmaceuticals, LLC 2020-07-15
71205-0624-04 118 mL in 1 BOTTLE (71205-624-04) Codeine-Guaifenesin Proficient Rx LP 2021-12-03
72162-1669-02 120 mL in 1 BOTTLE (72162-1669-2) Codeine-Guaifenesin Bryant Ranch Prepack 2024-03-22
Observed labelers: PAI Holdings, LLC (7) · A-S Medication Solutions (2) · Method Pharmaceuticals, LLC (2) · Westminster Pharmaceuticals, LLC (2) · Bryant Ranch Prepack (1) · Cardinal Health 107, LLC (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.